The Family of the Interleukin-1 Receptors
Overview
General Surgery
Affiliations
The extracellular forms of the IL-1 cytokines are active through binding to specific receptors on the surface of target cells. IL-1 ligands bind to the extracellular portion of their ligand-binding receptor chain. For signaling to take place, a non-binding accessory chain is recruited into a heterotrimeric complex. The intracellular approximation of the Toll-IL-1-receptor (TIR) domains of the 2 receptor chains is the event that initiates signaling. The family of IL-1 receptors (IL-1R) includes 10 structurally related members, and the distantly related soluble protein IL-18BP that acts as inhibitor of the cytokine IL-18. Over the years the receptors of the IL-1 family have been known with many different names, with significant confusion. Thus, we will use here a recently proposed unifying nomenclature. The family includes several ligand-binding chains (IL-1R1, IL-1R2, IL-1R4, IL-1R5, and IL-1R6), 2 types of accessory chains (IL-1R3, IL-1R7), molecules that act as inhibitors of signaling (IL-1R2, IL-1R8, IL-18BP), and 2 orphan receptors (IL-1R9, IL-1R10). In this review, we will examine how the receptors of the IL-1 family regulate the inflammatory and anti-inflammatory functions of the IL-1 cytokines and are, more at large, involved in modulating defensive and pathological innate immunity and inflammation. Regulation of the IL-1/IL-1R system in the brain will be also described, as an example of the peculiarities of organ-specific modulation of inflammation.
The Golden Card of Interleukin-1 Blockers in Systemic Inflammasomopathies of Childhood.
Rigante D Int J Mol Sci. 2025; 26(5).
PMID: 40076498 PMC: 11899952. DOI: 10.3390/ijms26051872.
Liu F, Li K Mol Cell Biochem. 2025; .
PMID: 40029555 DOI: 10.1007/s11010-025-05238-7.
Toll-like receptor signaling in teleosts.
Su J Sci China Life Sci. 2025; .
PMID: 39961973 DOI: 10.1007/s11427-024-2822-5.
Andersen L, Abernathy J, Farmer B, Lange M, Sankappa N, McEntire M Mar Biotechnol (NY). 2025; 27(2):51.
PMID: 39961922 DOI: 10.1007/s10126-025-10431-2.
Feng Y, Chen C, Shao A, Wu L, Hu H, Zhang T Acta Pharm Sin B. 2025; 14(12):5091-5105.
PMID: 39807338 PMC: 11725142. DOI: 10.1016/j.apsb.2024.09.008.